Home > Insider Trading > Filing (0001012975-14-000433)

Filing Details

Accession Number:: 0001012975-14-000433
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-06-25 17:06:34
Reporting Period:: 2013-06-13

Filing Date:: 2014-06-25
Accepted Time:: 2014-06-25 17:06:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1311241	Intermolecular Inc	IMI	Semiconductors & Related Devices (3674)	201616267

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1266748	Cmea Ventures Vi Lp	1 Letterman Dr., Bldg. C, Suite Cm500 San Francisco CA 94129	Yes	No	Yes	No
1340886	J David Collier	1 Letterman Dr., Bldg. C, Suite Cm500 San Francisco CA 94129	Yes	No	Yes	No
1420406	F James Watson	1 Letterman Dr., Bldg. C, Suite Cm500 San Francisco CA 94129	Yes	No	Yes	No
1425394	A. Faysal Sohail	1 Letterman Dr., Bldg. C, Suite Cm500 San Francisco CA 94129	Yes	No	Yes	No
1527296	Cmea Ventures Vi Gmbh & Co. Kg	1 Letterman Dr., Bldg. C, Suite Cm500 San Francisco CA 94129	Yes	No	Yes	No
1527297	Cmea Ventures Vi Management, L.p.	1 Letterman Dr., Bldg. C, Suite Cm500 San Francisco CA 94129	Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2013-06-13	999,529	$0.00	6,375,971	No	4	J	Direct
Common Stock	Disposition	2013-06-13	22,891	$0.00	150,052	No	4	J	Direct
Common Stock	Disposition	2013-06-13	20,218	$0.00	0	No	4	J	Direct
Common Stock	Disposition	2013-06-14	3,546	$7.25	0	No	4	S	Direct
Common Stock	Disposition	2013-06-14	3,546	$7.28	0	No	4	S	Direct
Common Stock	Disposition	2013-07-05	3,146	$7.42	400	No	4	S	Direct
Common Stock	Disposition	2013-07-09	400	$7.34	0	No	4	S	Direct
Common Stock	Disposition	2013-09-09	999,529	$0.00	5,376,442	No	4	J	Direct
Common Stock	Disposition	2013-09-09	22,891	$0.00	127,161	No	4	J	Direct
Common Stock	Disposition	2013-09-09	20,218	$0.00	0	No	4	J	Direct
Common Stock	Disposition	2013-09-12	3,546	$5.61	0	No	4	S	Direct
Common Stock	Disposition	2014-03-12	999,529	$0.00	4,376,913	No	4	J	Direct
Common Stock	Disposition	2014-03-12	22,891	$0.00	104,270	No	4	J	Direct
Common Stock	Disposition	2014-03-12	20,218	$0.00	0	No	4	J	Direct
Common Stock	Disposition	2014-03-13	1,528	$2.72	2,018	No	4	S	Direct
Common Stock	Disposition	2014-03-14	1,307	$2.75	711	No	4	S	Direct
Common Stock	Disposition	2014-03-14	1,251	$2.75	5,841	No	4	S	Direct
Common Stock	Disposition	2014-03-17	1,241	$2.75	4,600	No	4	S	Direct
Common Stock	Disposition	2014-03-18	711	$2.75	0	No	4	S	Direct
Common Stock	Disposition	2014-03-19	1,800	$2.83	2,800	No	4	S	Direct
Common Stock	Disposition	2014-03-20	1,800	$2.86	1,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	J	Direct
No	4	J	Direct
No	4	J	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	J	Direct
No	4	J	Direct
No	4	J	Direct
No	4	S	Direct
No	4	J	Direct
No	4	J	Direct
No	4	J	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Distribution of shares in kind by CMEA Ventures VI, L.P. ("CMEA VI") on a pro rata basis to its partners.
The shares are directly held by CMEA VI. The general partner of CMEA VI is CMEA Ventures VI Management, L.P. ("CMEA GP"). The general partners of CMEA GP include Faysal Sohail ("Sohail"), James Watson ("Watson") and David Collier ("Collier", and collectively with Sohail and Watson, the "General Partners") and, as such, each of CMEA GP and the General Partners exercises shared voting and investment power over the shares held of record by CMEA VI. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.
Distribution of shares in kind by CMEA Ventures VI GmbH & Co. KG ("CMEA VI GmbH") on a pro rata basis to its partners.
The shares are directly held by CMEA VI GmbH. The managing limited partner of CMEA VI GmbH is CMEA GP and, as such, each of CMEA GP and the General Partners exercises shared voting and investment power over the shares held of record by CMEA VI GmbH. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.
CMEA GP received shares distributed in kind by CMEA VI and CMEA VI GmbH on a pro rata basis to each such Reporting Person's partners and, in turn, made a distribution of shares in kind on a pro rata basis to its own partners. Each of the Reporting Persons disclaims beneficial ownership of CMEA GP's shares except to the extent of their pecuniary interest therein, if any.
Each General Partner received shares distributed in kind by CMEA GP on a pro rata basis to its partners.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.20 to $7.30, inclusive. Collier undertakes to provide to Intermolecular, Inc., any security holder of Intermolecular, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares are directly held by Collier.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.265 to $7.30, inclusive. Watson undertakes to provide to Intermolecular, Inc., any security holder of Intermolecular, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares are directly held by Watson.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.36 to $7.45, inclusive. Sohail undertakes to provide to Intermolecular, Inc., any security holder of Intermolecular, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares are directly held by Sohail.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.29 to $7.37, inclusive. Sohail undertakes to provide to Intermolecular, Inc., any security holder of Intermolecular, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.58 to $5.65, inclusive. Collier undertakes to provide to Intermolecular, Inc., any security holder of Intermolecular, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.69 to $2.78, inclusive. Collier undertakes to provide to Intermolecular, Inc., any security holder of Intermolecular, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.72 to $2.79, inclusive. Collier undertakes to provide to Intermolecular, Inc., any security holder of Intermolecular, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.72 to $2.79, inclusive. Watson undertakes to provide to Intermolecular, Inc., any security holder of Intermolecular, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.72 to $2.82, inclusive. Watson undertakes to provide to Intermolecular, Inc., any security holder of Intermolecular, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.825 to $2.89, inclusive. Watson undertakes to provide to Intermolecular, Inc., any security holder of Intermolecular, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.85 to $2.89, inclusive. Watson undertakes to provide to Intermolecular, Inc., any security holder of Intermolecular, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.